Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-03-04
2008-08-05
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023500, C536S024310, C536S024330
Reexamination Certificate
active
07407756
ABSTRACT:
This invention relates to methods and compositions useful for detecting mutations which cause Familial Dysautonomia. Familial dysautonomia (FD; Riley-Day syndrome), an Ashkenazi Jewish disorder, is the best known and most frequent of a group of congenital sensory neuropathies and is characterized by widespread sensory and variable autonomic dysfunction. Previously, we mapped the FD gene, DYS, to a 0.5 cM region of chromosome 9q31 and showed that the ethnic bias is due to a founder effect, with >99.5% of disease alleles sharing a common ancestral haplotype. To investigate the molecular basis of FD, we sequenced the minimal candidate region and cloned and characterized its 5 genes. One of these, IKBKAP, harbors two mutations that can cause FD. The major haplotype mutation is located in the donor splice site of intron 20. This mutation can result in skipping of exon 20 in the mRNA from FD patients, although they continue to express varying levels of wild-type message in a tissue-specific manner. RNA isolated from patient lymphoblasts is primarily wild-type, whereas only the deleted message is seen in RNA isolated from brain. The mutation associated with the minor haplotype in four patients is a missense (R696P) mutation in exon 19 that is predicted to disrupt a potential phosphorylation site. Our findings indicate that almost all cases of FD are caused by an unusual splice defect that displays tissue-specific expression; and they also provide the basis for rapid carrier screening in the Ashkenazi Jewish population.
REFERENCES:
patent: 5387506 (1995-02-01), Blumenfeld et al.
patent: 5597898 (1997-01-01), Ghosh
patent: 5891719 (1999-04-01), Cohen et al.
patent: 5968740 (1999-10-01), Fodor et al.
patent: 5998133 (1999-12-01), Blumenfeld et al.
patent: 6262250 (2001-07-01), Blumenfeld et al.
patent: 2002/0168656 (2002-11-01), Rubin et al.
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: 1 225 232 (2002-07-01), None
patent: 2722295 (1996-01-01), None
patent: 93/24657 (1993-12-01), None
patent: WO 99/25730 (1999-05-01), None
patent: 01/68917 (2001-09-01), None
patent: 02/059381 (2002-08-01), None
Mull et al. American Journal of Human Genetics. Oct. 1999. 64(4), A377, abstract 2129.
Gill et al. American Journal of Human Genetics. Oct. 1999. 65(4), p. A186, abstract 1023.
Anderson, et al., 2001, “Familial Dysautonomia is Caused by Mutations of the IKAP Gene,” Am. J. Hum. Genet., 68: 753-758.
Cohen, et al., 1998, “IKAP is a scaffold protein of the IκB kinase complex,” Nature, 395:292-296.
Cuajungco, 2001, “Cloning characterization, and genomic structure of the mouse Ikbkap gene” DNA Cell Biol. 20(9):579-86.
Dong et al., 2002, “Familial dysautonomia: detection of the IKAP IVS20(+6T—C) and R696P mutations and frequencies among Ashkenazi Jews” Am. J. Med. Genet. 110(3):253-257.
Gill et al., NCBI Database, National Library of Medicine, NIH (Bethesda, MD). Genbank Accession No. AF153419 Jan. 2, 2001.
Krappmann et al., 2000, “The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component” J. Biol. Chem. 275(38):29779-29787.
Slaugenhaupt, et al., Database EMBL 'Online! EBI; “Homo sapiensIkappaBkinase complex-associated protein (IKBKAP)mRNA,” retrieved from HTTP://www.EBI.AC.UK, Database accession No.: AF153419, Jan. 2, 2001 updated Feb. 28, 2001.
Slaugenhaupt, et al., 2001, “Tissue-Specific Express of a Splicing Mutation in theIKBKAPGene Causes Familial Dysautonomia,” Am. J. Hum. Genet., 68:598-605.
Takeoka et al., 2001, “Amino Acid Substitutions in the IKAP gene product significantly increases risk for bronchial asthma in children” J. Hum. Genet. 46(2):57-63.
US Appl. No. 60/262,284, filed Jan. 17, 2001 by Rubin et al.
U.S. Appl. No. 10/041,856, filed Jan. 7, 2002, Susan Slaugenhaupt et al.
U.S. Appl. No. 10/806,573, filed Mar. 22, 2004, Anat Blumenfeld et al.
U.S. Appl. No. 10/221,836, filed Oct. 1, 2003, Anat Blumenfeld et al.
Gill et al., “Survey of Ashkenazi Jewish SNPs in a 471 kb Region of Chromosome 9q31 as Compared to the Public SNP Database (dbSNP),” The American Journal of Human Genetics, vol. 69, No. 4, Oct. 2001.
Slaugenhaupt et al., “Characterization of the Spicing Mutation in IKBKAP that Causes Familial Dysautonomia,” The American Journal of Human Genetics, A2763, vol. 69, No. 4, Oct. 2001.
Leyne et al., “Complete Genomic Sequence of the 471 kb Familial Dysautonomia Candidate Region on Chromosome 9q31,” The American Journal of Human Genetics, vol. 65, No. 4, Oct. 1999.
Slaugenhaupt et al., “Saturation of the Genetic Map and Expansion of the Physical Map Surrounding the Familial Dysautonomia Gene on Human Chromosome 9,” Annals of Human Genetics, vol. 61, part 3, p. 223, May 1997.
Blumenfeld et al., “Carrier Diagnosis of Familial Dysautonomia Using Linkage Disequilirbrium Analysis,” The American Journal of Human Genetics, vol. 59, No. 4, Oct. 1996.
Slaugenhaupt et al., “Refinement of the Candidate Region and Isolation of Candidate Genes for Familial Dysautonomia on Human Chromosome 9q31,” The American Journal of Human Genetics, vol. 59, No. 4, Oct. 1996.
Leyne et al., “Analysis and Complete Genomic Sequence of the Refined 178 kb Familial Dysautonomia Candidate Region Chromosome 9q31,” The American Journal of Human Genetics, vol. 67, No. 4, Oct. 2000.
Blumenfeld et al., “Localization of the Gene for Familial Dysautonomia on Chromosome 9 and Definition of DNA Markers for Genetic Diagnosis,” Nature Genetics, vol. 4, pp. 160-164, Jun. 1993.
Eng et al., “Prenatal Diagnosis of Familial Dysautonomia by Analysis of Linked CA-Repeat Polymorphisms on Chromosome 9q31-q33,” American Journal of Medical Genetics, vol. 59, pp. 349-355, 1995.
Blumenfeld et al., “Precise Genetic Mapping and Haplotype Analysis of the Familial Dysautonomia Gene on Human Chromosome 9q31,” American Journal of Medical Genetics, vol. 64, pp. 1110-1118, 1999.
Chadwick et al., “Cloning, Mapping, and Expression of a Novel Brain-Specific Transcript in the Familial Dysautonomia Candidate Region on Chromosome 9q31,” Mammalian Genome, vol. 11, pp. 81-83, 2000.
Gusella, James F. “Mechanism of Familial Dysautonomia,” CRISP abstract for grant application to the National Institute of Neurological Disorders and Stroke, Project Start : Apr. 15, 1997. Accompanying grant application included.
Boehringer Mannheim, Biochemicals for Molecular Biology. 1995, p. 136.
S. L. Anderson, et al., “Familial Dysautonomia is Caused by Mutations of the IKAP Gene,” Am. J. Hum. Genet, 68:753-758, 2001.
Cuajungco et al., Society for Neuroscience Abstracts, 27(2), p. 2061, Nov. 10-15, 2001.
Leyne et al., Am. J. Med. Genetics, vol. 118A, pp. 305-308, 2003.
Demacio et al., Genome, vol. 44, pp. 990-994, 2001.
Hirschhorn et al., Genetics in Medicine, vol. 4, No. 2, pp. 45-61, Mar. 2002.
Ioannidis, Nature Genetics, vol. 29, pp. 306-309, Nov. 2001.
Oddoux et al., Prenatal Diagnosis, vol. 15, pp. 817-826, 1995.
Coli et al., “Genomic Organization and Chromosomal Localization of the mouse for IKBKAP Gene”, Gene, 279:81-89, 2001.
English Abstract of FR 2722295.
Lathrop et al., 1998, “Mapped set of Genetic Markers for Human Chromosome 9,” Genomics 3:361-366.
Proceedings of the 8th International Congress of Human Genetics, Washington, D.C., USA, Oct. 6-11, 1991, Am J Human Genet 49 (4 Suppl.). 1991. 336. Coden: AJHGAG ISSN: 0002-9297 6—(C) File Biosis Blumenfeld A., et al., “Advances in Linkage Analysis in Familial Dysautonomia”.
Blumenfeld A. et al. Linkage Analysis in Familial Dysautonomia, Bonne-Tamir, B. and A. Adam (Ed.) Genetic Diversity Among Jews: Disease and Markers of the DNA Level; Goodman's International Conference Israel, Jun. 1990, XXVIII +460P. Oxford University Press: New York, New York, USA, pp. 179-193.
Blumenfeld et al., 1993, “Exclusi
Gusella James F.
Slaugenhaupt Susan
King & Spalding LLP
Myers Carla
The General Hospital Corporation
LandOfFree
Methods for detecting mutations associated with familial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting mutations associated with familial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting mutations associated with familial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3998281